SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-07-109378
Filing Date
2007-05-10
Accepted
2007-05-10 09:25:50
Documents
10
Period of Report
2007-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d10q.htm 10-Q 246180
2 MASTER PURCHASE AND SALE AND LICENSE AGREEMENT dex1058.htm EX-10.58 454568
3 LICENSE AGREEMENT BETWEEN SALIX PHARMACEUTICALS, INC. AND DR. FALK PHARMA GMBH dex1059.htm EX-10.59 342897
4 SECTION 302 CEO CERTIFICATION dex311.htm EX-31.1 9576
5 SECTION 302 CFO CERTIFICATION dex312.htm EX-31.2 9736
6 SECTION 906 CEO CERTIFICATION dex321.htm EX-32.1 2971
7 SECTION 906 CFO CERTIFICATION dex322.htm EX-32.2 3172
8 GRAPHIC g81678img001.jpg GRAPHIC 4499
9 GRAPHIC g81678img002.jpg GRAPHIC 8352
10 GRAPHIC g81678img003.jpg GRAPHIC 12661
  Complete submission text file 0001193125-07-109378.txt   1106163
Mailing Address 1700 PERIMETER PARK DRIVE MORRISVILLE NC 27560
Business Address 1700 PERIMETER PARK DRIVE MORRISVILLE NC 27560 (919) 862-1000
SALIX PHARMACEUTICALS LTD (Filer) CIK: 0001009356 (see all company filings)

IRS No.: 943267443 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-23265 | Film No.: 07835124
SIC: 2834 Pharmaceutical Preparations